VeriMomБезопасен ли dihydromyricetin при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
Pregnancy-safe products containing dihydromyricetin
Related ingredients
Frequently asked questions
- Безопасен ли dihydromyricetin при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
- Безопасен ли dihydromyricetin при грудном вскармливании?
- No data indicating reproductive or lactation-specific toxicity or harmonised classifications. No demonstrated mechanism for transfer into milk; systemic exposure from topical use is likely low but measurable, so breastfeeding exposure is scored low (PubMed, PubChem, CosIng; no CIR/SCCS flags).
- Безопасен ли dihydromyricetin для кожи малыша?
- No infant-specific toxicity or developmental skin studies were identified. Hazard and mechanistic scores remain 0 due to absence of reproductive/endocrine evidence. Because infant skin has higher permeability and surface-area-to-weight, exposure is increased by +1 versus adult (adult e=1 → infant e=2) for measurable-absorption ingredients (sources: PubMed, CosIng, EWG; no harmonised CLP or SCCS/CIR restrictions).
- Как VeriMom оценивает dihydromyricetin?
- VeriMom оценивает dihydromyricetin в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы dihydromyricetin при беременности?
- См. наш список безопасных альтернатив dihydromyricetin с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.